AIDS: Vaccine shows positive results in small trial - researchers

Oct 19, 2009

An HIV vaccine tested in Tanzania has shown positive results in preliminary trials and may provide better protection than a promising Thai vaccine unveiled on September 24, Swedish researchers said Monday.

"We hope that our could increase protection to 50 percent," Britta Wahren, a professor emeritus at Sweden's Karolinska Institute and one of the researchers involved in the study, told AFP.

The vaccine in Thailand tested by Thai and US researchers cuts the risk of infection by a third, an achievement described by the (WHO) as a "significant scientific advance."

"Our vaccine includes more strains of the virus -- from Europe, Africa, the US and Asia -- and therefore provides a broader protection," Wahren said.

The Swedish vaccine, called Hivis, was tested on 60 healthy policemen in Tanzania in what is called a Phase II study.

This is the stage between a Phase I trial, when a vaccine is tested on a very small group of volunteers to assess its safety, and a Phase III trial, a large-scale investigation among thousands of people that focusses especially on effectiveness.

The researchers looked at whether the vaccine was safe to use and how the body's reacted to it.

The results were so encouraging that the researchers are keen to carry Phase III testing, Wahren said.

"We don't have the financing to do that yet. But we hope that we will get it after presenting our results," Wahren said.

The results have not yet been published in a scientific journal but are to be presented at an HIV/ vaccine conference in Paris on Wednesday.

Manuel Romaris, the scientific officer in charge of research on HIV/AIDS at the European Commission, said the Swedish vaccine had shown the most promising preliminary results so far.

"It is the best preliminary result I know of for a vaccine of this type ... The Swedish researchers seem to be on the right path," Romaris told leading Swedish paper Dagens Nyheter.

"I don't think the Thai vaccine's results were as good in the early stages," he added.

The Thai vaccine was tested on 16,000 healthy Thai people in a Phase III study.

(c) 2009 AFP

Explore further: HIV pills show more promise to prevent infection

add to favorites email to friend print save as pdf

Related Stories

A world first: Vaccine helps prevent HIV infection

Sep 24, 2009

(PhysOrg.com) -- In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving ...

How HIV vaccine might have increased odds of infection

Nov 03, 2008

In September 2007, a phase II HIV-1 vaccine trial was abruptly halted when researchers found that the vaccine may have promoted, rather than prevented, HIV infection. A new study by a team of researchers at the Montpellier ...

Experimental aids vaccine now in production

Nov 12, 2008

(PhysOrg.com) -- The advance towards a vaccine for HIV/AIDS has taken another step closer to realization. A vaccine, developed by Dr. Chil-Yong Kang and his team at the Schulich School of Medicine & Dentistry at The University ...

AIDS vaccine trial exceeds expectations

Sep 23, 2005

An experimental AIDS vaccine of Merck & Co. has exceeded expectations and led to a double enrollment in the trial to 3,000, researchers said.

Puzzling results from HIV vaccine trial

Dec 03, 2007

A potential HIV vaccine that recently failed a clinical trial in the United States may increase some people's chance of catching the virus that causes AIDS.

Scientists lose hope over AIDS vaccine

Apr 25, 2008

A survey of leading U.S. and British AIDS researchers said many scientists see little hope of an effective vaccine against HIV in the near future.

Recommended for you

HIV pills show more promise to prevent infection

3 hours ago

There is more good news about HIV treatment pills used to prevent infection in people at high risk of getting the AIDS virus: Follow-up from a landmark study that proved the drug works now shows that it does ...

User comments : 0